Searchable abstracts of presentations at key conferences in endocrinology

ea0056ep120 | Pituitary and Neuroendocrinology | ECE2018

Macroprolactinoma found in obesity setting: case report

Sofia Osorio Ana , Filipa Martins Ana , Vieira Joao , Barbosa David , Faria Carolina , Nobre Ema , Joao Bugalho Maria

Obesity is growing fast worldwide. Although environmental factors play a major role, endocrine dysfunction may contribute to the weight gain. We report an invasive macroprolactinoma diagnosed in obesity setting. A 35-year-old male was referred to our endocrine outpatient department due to grade 2 obesity (IMC 38.4 Kg/m2). His weight was increasing since the beginning of his professional activity at the age of 20 due to a sedentary lifestyle. On physical examination he had an h...

ea0081p741 | Thyroid | ECE2022

Efficacy of radioactive iodine treatment in Graves Disease using a calculated 131I dose and predictive factors of success in a Portuguese cohort

Franco Sara , Teixeira Ferreira Rita , Cardoso Ferreira Ines , Quitalo Ana , Barbosa David , Manuel Costa Maria , Vara Luiz Henrique , Raimundo Luisa , Isabel Santos Ana

Aim: Dose corrected for thyroid gland size is one of the methods used to determine radioactive iodine (RAI) activity for patients with Graves disease (GD). This study was aimed to investigate the real-world success rate of this method and the predictors of success after first treatment.Methods: This is a retrospective study of 80 patients with GD treated between 2014 and 2020 in a tertiary referral hospital in Almada, Portugal. The successful group was d...

ea0090p388 | Endocrine-related Cancer | ECE2023

PRRT 177Lu-DOTA-TATE in pancreatic neuroendocrine tumors – When to initiate?

Franco Sara , Lucena Sampaio Ines , Ferreira Goncalo , Barbosa Daniel , Gil-Santos Sara , Vara Luiz Henrique , Paula Santos Ana , Torres Isabel , Duarte Hugo

Introduction: The best timing for PRRT (peptide receptor radionuclide therapy) in the case of pancreatic neuroendocrine tumors (panNETs) is still to define, as randomized prospective trials are lacking. Recent studies suggest that some systemic therapies can affect response to PRRT, favoring an earlier use of the latter.Objective: To determine the efficacy and toxicity of PRRT, comparing its results when used as a second line systemic therapy (a...

ea0049ep1465 | Thyroid (non-cancer) | ECE2017

Isolated bone metastases: a rare form of presentation of papillary thyroid carcinoma

Peyroteo Mariana , Ribeiro Catia , Martins Pedro C , Ferreira Ana , Giesteira Laurinda , Barbosa Rui , Carvalho Machado , Ramalho Antonio , Moreira Augusto , de Sousa Abreu

Background: Papillary thyroid cancer (PTC) is the most frequent type of well-differentiated thyroid cancer (WDTC) and frequently poses a management dilemma. Its indolent behavior associated with high long term survival support the trend towards a more conservative management approach. The authors present a case of isolated bone metastases as the form of presentation of papillary thyroid carcinoma. A 61-year-old man was admitted with complaints of lower back pain for the previo...

ea0037gp.05.10 | Developmental and paediatric endocrinology | ECE2015

Ghrelin and GHSR1 receptor in placentas of SGA, LGA, and AGA newborns

Gonzalez Dominguez Martha I , de la Vega Monrroy Maria Luisa Lazo , Zaina Silvio , Sabanero Myrna , Daza-Benitez Leonel , Malacara Juan Manuel , Barbosa-Sabanero Gloria

Introduction: Intrauterine growth is a biological process regulated by maternal, placental, and foetal endocrine signals. Birth weight is an indicator of the health of the newborn. Alterations in foetal growth lead to perinatal health risks and favour metabolic diseases during adult life. Therefore, the study of endocrine factors determining birth weight, such as ghrelin is an important issue. Ghrelin may exist as two molecular forms, desacyl ghrelin (DAG) and acyl ghrelin (AG...

ea0070aep282 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Residual fasting C-peptide secretion and its association with glycemic control in type 1 diabetes

Lopes Sara , Barbosa Mariana , Barros Inês , Sá Juliana , Joana Santos Maria , Margarida Monteiro Ana , Fernandes Vera , Matos Catarina , Lopes Pereira Maria , Marques Olinda , Alves Marta

Background: Residual C-peptide (CP) secretion has been associated with better glycemic control in patients with type 1 diabetes (T1D).Aim: To evaluate how residual fasting CP (fCP) secretion impacts glycemic control in T1D and to identify possible confounding factors.Methods: A retrospective analysis of adult patients with T1D followed in our department that had their fCP and glucose levels obtained on the same blood sample during ...

ea0070aep477 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Comparison of basal metabolism rate assessment in athletes using indirect calorimetry, bioimpedance, and wearable monitors

Fernandes Oliveira-Filho Antonio , Nunes Adriana , Cavalcanti Cruz Wesley , Carla Silva Lima Erika , Cosmo Rocha Lucas , Candeia Gurjao Edmar , Eduardo Silva Barbosa Paulo

Wearable physical activity monitors are growing in popularity as they provide the opportunity for self-monitoring, real time data collection and data sharing for cardiovascular and sports medicine. However, there are discussions about the accuracy of their energy expenditure estimate. This study examined and compared basal metabolic rate through indirect calorimetry and through wrist-worn devices and bioimpedance. The group consisted of 30 healthy male individuals, professiona...

ea0070aep484 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Flash glucose monitoring system: Impact on glycaemic control and body mass index in type 1 diabetes mellitus

Sá Juliana , Lopes Sara , Barbosa Mariana , Ferreira Barros Inês , Margarida Monteiro Ana , Fernandes Vera , Matos Catarina , Alves Marta , Lopes Pereira Maria , Marques Olinda , Joana Santos Maria

Background: The use of Flash Glucose Monitoring (FGM) for the management of type 1 diabetes mellitus (T1D) is rapidly increasing.Aims: To assess the longitudinal evolution of glycated haemoglobin (HbA1c) and body mass index (BMI) with the use of FGM in patients with T1D; to determine predictive factors of benefit with the use of this technology.Materials and methods: Retrospective study of T1D patients, using FGM ≥6 months an...

ea0070ep380 | Reproductive and Developmental Endocrinology | ECE2020

Effect of significant weight loss by very low calorie ketogenic diet on male obesity secondary hypogonadism and sexual function

Renck Alessandra , Afonso Teixeira Thiago , Roberto de Souza Marcio , de Nóvoa Cardoso Paulo , Barbosa Trarbach Ericka , Hallak Jorge , Maria Frade Costa Elaine

Obesity is the single most significant risk factor for testosterone deficiency in men, with a reported prevalence up of 60% of male obesity secondary hypogonadism (MOSH). Several studies have shown that significant weight loss due to bariatric surgery have significant metabolic and endocrine improvement in obesity, however the results achieved with conventional diet and lifestyle change are poor and not able to reverse this condition. As an alternative to bariatric surgery, we...

ea0032p625 | Growth hormome IGF axis – basic | ECE2013

SNPs within the GH signaling pathway are associated with the fast, but not the long term, IGF1 response to GH replacement therapy in GH deficient adults

Glad Camilla , de Jesus Litenski Barbosa Edna , Filipsson Nystrom Helena , Carlsson Ekander Lena , Nilsson Staffan , Nilsson Anna , Svensson Per-Arne , Johannsson Gudmundur

Introduction: GH deficiency (GHD) in adults is associated with low serum levels of insulin-like growth factor 1 (IGF1) and a deteriorated cardio-metabolic profile. GH replacement therapy (GHRT) increases serum IGF1, an important mediator of the treatment response and safety marker of dose titration. The interindividual variation in treatment response is large and most likely influenced by genetic factors.Aim: The aim of this study was to test the hypothe...